Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine

Infection and Immunity

Volumn 70, Issue 6, 2002, Pages 2950-2958

  Venkatesan, Malabi M ^a   Hartman, Antoinette B ^a   Newland, John W ^a   Ivanova, Vessela S ^a   Hale, Thomas L ^a   McDonough, Marie ^a   Butterton, Joan ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; SC602; SHIGELLA VACCINE; UNCLASSIFIED DRUG; WRSD1; WRSS1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SYNTHESIS; GENE DELETION; GOOD MANUFACTURING PRACTICE; GUINEA PIG; IMMUNOGENICITY; KERATOCONJUNCTIVITIS; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SOUTHERN BLOTTING;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DNA-BINDING PROTEINS; DYSENTERY, BACILLARY; EYE INFECTIONS, BACTERIAL; GENETIC COMPLEMENTATION TEST; GUINEA PIGS; HELA CELLS; HUMANS; LIPOPOLYSACCHARIDES; MACACA MULATTA; MUTAGENESIS; POLYMERASE CHAIN REACTION; SHIGA TOXINS; SHIGELLA DYSENTERIAE; SHIGELLA VACCINES; TRANSCRIPTION FACTORS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0036263522     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.6.2950-2958.2002     Document Type: Article

References (34)

1. In vivo transduction with Shiga toxin 1-encoding phage
2. Construction and characterization of virG(icsA)-deleted Escherichia coli-Shigella flexneri hybrid vaccine strains
3. Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin
4. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602
5. Measurement of invasion by gentamicin resistance
6. Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes
7. Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1
8. Shigellosis due to Shigella dysenteriae 1: Relative importance of mucosal invasion versus toxin production in pathogenesis
9. Quantitative microtiter cytotoxicity assay for Shigella toxin
10. Construction of stable attenuated virG(icsA) Shigella sonnei vaccine strain WRSS1 and protective efficacy and immunogenicity studies in the guinea pig keratoconjunctivitis model
11. Small animal model to measure efficacy and immunogenicity of Shigella vaccine strains
12. Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family
13. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1
14. Global burden of Shigella infections: Implications for vaccine development and implementation of control strategies
15. Phase I evaluation of ΔvirG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults
16. Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery
17. Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome
18. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit
19. Genetic analysis of Escherichia coli K1 gastrointestinal colonization
20. Spontaneous tandem amplification and deletion of the Shiga toxin operon in Shigella dysenteriae 1
21. Epidemic Shiga-bacillus dysentery in Central America. Derivation of the epidemic and its progression in Guatemala, 1968-69
22. Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence
23. DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages
24. Shiga toxin mode of action in E. coli O157:H7 disease
25. Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1
26. Two copies of Shiga-like toxin II-related genes common in EHEC strains are responsible for the antigenic heterogeneity of the 0157:H- strain E32511
27. Experimental keratoconjunctivitis shigellosa
28. Cloning of the rfb gene region of Shigella dysenteriae 1 and construction of an rfb-rfp gene cassette for the development of lipopolysaccharide-based live anti-dysentery vaccines
29. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids
30. Towards a vaccine candidate against Shigella dysenteriae 1: Expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain
31. Structural analysis of phage-borne stx genes and their flanking sequences in Shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains
32. Complete DNA sequence and analysis of the large virulence plasmid of Shigella flexneri
33. Cloning and characterisation of the aroA and aroD genes of Shigella dysenteriae type 1
34. Bacterial lipopolysaccharide extraction with phenol:water and further application of the procedure